Jackson Center, PA, July 1, 2020 – Halberd Corporation (OTC-PINK: "HALB") announced the establishment of a subsidiary in the United Kingdom to facilitate access to European research facilities and markets. The subsidiary is Halberd Corporation UK, Ltd. William A. Hartman, Chairman, President & CEO of Halberd, stated, “This is the first step in our overall ...
Jackson Center, PA, June 29, 2020 – Halberd Corporation (OTC-PINK: "HALB") today unveils the first of three (3) COVID -19 (Coronavirus) patent pending treatment methods -- the first titled, “Method for Treating and Curing Covid-19 Infection” -- filed with the U.S. Patent and Trademark Office on March 16, 2020. Halberd holds exclusive worldwide license to ...
Effective Immediately! Jackson Center, PA, June 22, 2020 – Halberd Corporation (OTC Pink: HALB) announced the appointment of Dr. Patricio F. Reyes to the position of Chief Technical Officer effective immediately. He will report to Halberd’s new Chairman, President and CEO, William A. Hartman and is currently the Chief Medical Officer of the NFL’s Retired ...
Jackson Center, PA, June 15, 2020 –Halberd Corporation (OTC Pink: HALB) announced that OTC Markets has completed its background investigation and analysis of all filings by Halberd Corporation and now designates Halberd Corporation as "Pink Current Information". William A. Hartman, newly appointed Chairman, President and CEO explains, “Now that Halberd has been designated by OTC ...
Jackson Center, PA, June 9, 2020 – Halberd Corporation (OTC Pink: HALB) announced the appointment of Dr. Patricio F. Reyes to its Scientific Advisory Board effective immediately He will report to Halberd’s Chairman, President and CEO, William A. Hartman. Dr. Reyes, MD, FAAN, a board certified neurologist and neuropathologist, is a Board Member of the ...
Jackson Center, PA, April 8, 2020 – Premier Biomedical, Inc. (OTC-PINK: “BIEI“), Halberd Corporation (OTC-PINK: HALB) and Gold River Productions Inc. (OTC-PINK: GRPS) announce the signing of a multi-faceted agreement for ongoing R&D into a potential treatment and cure for Covid-19 as well as development of Premier’s Anti-Addiction PatchTM. The Joint Venture on Covid-19 treatment starts with Dr. Mitchell ...
Halberd announces agreement to retire 192,000,000 outstanding common shares and acquisition/joint venture to be announced, in detail, this week. Lake Charles, Louisiana -- April 3, 2020 - Halberd Corporation (PINKSHEETS: HALB) announces that it has reached an agreement with shareholders holding 192,000,000 shares of the 482,838,125 reported as currently outstanding. Those shares will be returned to ...
Halberd moves forward – announces new CEO, commences process to become current, holding company reorganization. SOUTHFIELD, MI-- April 1, 2020 - Halberd Corporation (PINKSHEETS: HALB) announces that James Christopher LeDoux is the new CEO. Mr. LeDoux explains that “Halberd is now current in its filings with the Colorado Secretary of State. The Colorado state filings ...